Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugene Dempsey

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
Oncotarget|April 13, 2018
BAG3 promotes tumour cell proliferation by regulating EGFR signal transduction pathways in triple negative breast cancerSarah Shields, Emer Conroy, Tony O'Grady, et al.
Oncotarget|May 30, 2019
Correction: BAG3 promotes tumour cell proliferation by regulating EGFR signal transduction pathways in triple negative breast cancerSarah Shields, Emer Conroy, Tony O'Grady, et al.
Trials|April 4, 2024
Does the use of higher versus lower oxygen concentration improve neurodevelopmental outcomes at 18-24 months in very low birthweight infants?Georg M Schmölzer, Elizabeth V Asztalos, Marc Beltempo, et al.
Plos One|March 23, 2017
Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trialAnne M Plomgaard, Thomas Alderliesten, Topun Austin, et al.
Frontiers in Molecular Neuroscience|September 27, 2021
Novel Point-of-Care Diagnostic Method for Neonatal Encephalopathy Using Purine NucleosidesEdward Beamer, Mary Isabel O'Dea, Aisling A Garvey, et al.
Pediatric Research|July 8, 2016
Recommendations for neonatologist performed echocardiography in Europe: Consensus Statement endorsed by European Society for Paediatric Research (ESPR) and European Society for Neonatology (ESN)Willem P de Boode, Yogen Singh, Samir Gupta, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|December 10, 2015
The SafeBoosC phase II clinical trial: an analysis of the interventions related with the oximeter readingsJoan Riera, Simon Hyttel-Sorensen, María Carmen Bravo, et al.
Pediatric Research|December 19, 2015
The SafeBoosC II randomized trial: treatment guided by near-infrared spectroscopy reduces cerebral hypoxia without changing early biomarkers of brain injuryAnne M Plomgaard, Wim van Oeveren, Tue H Petersen, et al.
Neonatology|August 8, 2013
The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infantsAdelina Pellicer, Gorm Greisen, Manon Benders, et al.
The Pediatric Infectious Disease Journal|September 18, 2015
Respiratory Syncytial Virus Preterm (32-36 Completed Weeks of Gestation) Risk Estimation Measure for RSV Hospitalization in Ireland: A Prospective StudyMargaret Sheridan-Pereira, Joan Murphy, Julie Sloan, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Oncotarget|April 13, 2018
BAG3 promotes tumour cell proliferation by regulating EGFR signal transduction pathways in triple negative breast cancerSarah Shields, Emer Conroy, Tony O'Grady, et al.
Oncotarget|May 30, 2019
Correction: BAG3 promotes tumour cell proliferation by regulating EGFR signal transduction pathways in triple negative breast cancerSarah Shields, Emer Conroy, Tony O'Grady, et al.
Trials|April 4, 2024
Does the use of higher versus lower oxygen concentration improve neurodevelopmental outcomes at 18-24 months in very low birthweight infants?Georg M Schmölzer, Elizabeth V Asztalos, Marc Beltempo, et al.
Plos One|March 23, 2017
Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trialAnne M Plomgaard, Thomas Alderliesten, Topun Austin, et al.
Frontiers in Molecular Neuroscience|September 27, 2021
Novel Point-of-Care Diagnostic Method for Neonatal Encephalopathy Using Purine NucleosidesEdward Beamer, Mary Isabel O'Dea, Aisling A Garvey, et al.
Pediatric Research|July 8, 2016
Recommendations for neonatologist performed echocardiography in Europe: Consensus Statement endorsed by European Society for Paediatric Research (ESPR) and European Society for Neonatology (ESN)Willem P de Boode, Yogen Singh, Samir Gupta, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|December 10, 2015
The SafeBoosC phase II clinical trial: an analysis of the interventions related with the oximeter readingsJoan Riera, Simon Hyttel-Sorensen, María Carmen Bravo, et al.
Pediatric Research|December 19, 2015
The SafeBoosC II randomized trial: treatment guided by near-infrared spectroscopy reduces cerebral hypoxia without changing early biomarkers of brain injuryAnne M Plomgaard, Wim van Oeveren, Tue H Petersen, et al.
Neonatology|August 8, 2013
The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infantsAdelina Pellicer, Gorm Greisen, Manon Benders, et al.
The Pediatric Infectious Disease Journal|September 18, 2015
Respiratory Syncytial Virus Preterm (32-36 Completed Weeks of Gestation) Risk Estimation Measure for RSV Hospitalization in Ireland: A Prospective StudyMargaret Sheridan-Pereira, Joan Murphy, Julie Sloan, et al.
Pageof 13